Return to study ST003117 main page
MB Sample ID: SA341379
| Local Sample ID: | ID_44 |
| Subject ID: | SU003273 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Gender: | Male and female |
Select appropriate tab below to view additional metadata details:
Collection:
| Collection ID: | CO003266 |
| Collection Summary: | Individuals with P. vivax were admitted at the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), a reference center for infectious diseases located in Manaus, Western Brazilian Amazon. At inclusion into the CURAVIVAX study, patient socio-demographic data including sex, age, weight, body-mass index and ethnicity was captured. Laboratory analyses were done at pre-treatment through the treatment days and follow-up including the day of recurrence. Patients of both sexes, aged > 6 months, body weight ≥ 5 kg, with symptomatic P. vivax monoinfection, parasite density between 100 and 100,000 parasites/ µL were included. Exclusion criteria included the use of antimalarials in the last 60 days, mixed Plasmodium infections especially P. falciparum, pregnancy, or lactation and concomitant or underlying diseases. Patients with dengue and other febrile diseases were excluded during screening. After confirmation of malaria vivax by thick blood smears, whole blood and plasma samples were collected, aliquoted and stored at -80OC until needed for analysis. Plasma samples for day of inclusion and before treatment (D0), day six (D6), day ninety (D90) and recurrence day (DR) were used for this study. |
| Sample Type: | Blood (plasma) |
| Storage Conditions: | -80℃ |
